SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning. - Wikidata - awgldk - TriplyDB

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

http://www.wikidata.org/entity/Q33756417

about

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation Hypoxia-inducible factors as molecular targets for liver diseases Potential for developing purinergic drugs for gastrointestinal diseases Attenuating myocardial ischemia by targeting A2B adenosine receptors Adenosine receptors as drug targets--what are the challenges?Partial netrin-1 deficiency aggravates acute kidney injury Purinergic signaling during inflammation.Adenosine signaling during acute and chronic disease states Extracellular nucleotide and nucleoside signaling in vascular and blood disease The resurgence of A2B adenosine receptor signaling Ischemic preconditioning in the liver is independent of regulatory T cell activity.CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.Decreased extracellular adenosine levels lead to loss of hypoxia-induced neuroprotection after repeated episodes of exposure to hypoxia.Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation.CD39 improves survival in microbial sepsis by attenuating systemic inflammation Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia Use of a hanging weight system for coronary artery occlusion in mice.Pressure controlled ventilation to induce acute lung injury in mice The hypoxia-inflammation link and potential drug targets.Coexpression of ecto-5'-nucleotidase/CD73 with specific NTPDases differentially regulates adenosine formation in the rat liver.Metabolism of circulating ADP in the bloodstream is mediated via integrated actions of soluble adenylate kinase-1 and NTPDase1/CD39 activities Extracellular adenosine levels are associated with the progression and exacerbation of pulmonary fibrosis.Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury.Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease.Extracellular adenosine signaling in molecular medicine CD73+ regulatory T cells contribute to adenosine-mediated resolution of acute lung injury.CD39 and CD73 in immunity and inflammation.Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury Signaling through hepatocellular A2B adenosine receptors dampens ischemia and reperfusion injury of the liver.Purinergic dysregulation in pulmonary hypertension Protective role for netrin-1 during diabetic nephropathy.Equilibrative nucleoside transporter (ENT)-1-dependent elevation of extracellular adenosine protects the liver during ischemia and reperfusion Biological implications of extracellular adenosine in hepatic ischemia and reperfusion injury.Hypoxia signaling during intestinal ischemia and inflammation.Ischemia and reperfusion--from mechanism to translation.Perioperative organ injury.CD73-dependent generation of adenosine and endothelial Adora2b signaling attenuate diabetic nephropathy.Pathological roles of purinergic signaling in the liver The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury.

P2860

Q21131166-E7395271-6176-4967-BDC2-A16640DB3ECD Q26752304-A8ACF1A6-8F93-4624-9B5D-331E76FC1515 Q27000719-1D5D780C-4B54-46CC-9350-77883AC6C773 Q27006863-80FBA248-26C7-4E15-97BA-43F10352A372 Q29346491-A9D9642F-12FD-402B-88B5-5CF7737F063B Q33916670-F269157A-76E1-4BFD-BC3E-707E828857C8 Q34034751-2DB7AE9D-7C82-4B79-8831-A5417783460C Q34035228-19AC0DBC-FC89-435D-BEC6-CCB201DE403C Q34047834-D1A6BE58-EC55-4AAE-9E74-1550669D78D8 Q34307284-9CB86914-998D-4102-A0DF-4146D515E6F8 Q34490320-658FDDAE-836D-4937-ACD2-8A86BA641943 Q34569461-6497B742-67D3-4ECC-8E42-62CF0A14C2DF Q34599971-47E1E311-BF56-4C2B-B50A-C13902681AC9 Q34657382-F70FAD3C-5223-47D4-9708-F9154F21FF97 Q34707637-02350C5F-53D4-47C4-9896-B95D08A874CD Q34847971-66F8F3B2-E19C-4FD1-BBF3-F49E5AAA472C Q35193886-8CA0FE1A-E17F-4D0E-8632-0B9C0EB39380 Q35203103-4889B596-0B4E-4902-9136-B039A2DB65F9 Q35392090-F501918E-394E-44E0-9888-A5131F99CC6D Q35676172-C6534E58-ECEC-4D87-9200-CEE02B3CFA09 Q35780855-0FB455C4-0093-46B6-B506-CA8814E9AA2B Q36183732-7DD9CADA-03CD-4A8C-9036-F9AE3A490B1F Q36467021-234DB2EE-3CC4-4AC5-84CF-4AAB4BB939AB Q36507134-3C95283D-5BF3-4DDE-82CC-0AB20C4FF33C Q36575943-24501B3E-717E-4B0A-840C-615A36EEDCA6 Q36585539-BC5B7AFD-DAC0-4F83-A91A-7C99FA30A9D2 Q36860320-B68A1C56-01A8-4CB0-875D-10E403F7196C Q36906658-F2CE7E61-63A5-487E-B83E-0333F154A4F3 Q37022867-BE492A83-F8B7-409E-B562-521303EFFFC0 Q37031849-E3C850D3-4742-4370-8A6E-5E7CA3C9FCEB Q37139591-4A14B19D-9BFD-45B2-8E8D-845284C6983F Q37154417-768A451E-5285-4170-9578-BC5D54692949 Q37227567-1E19CDC1-D7A0-49DE-907B-EECE218D13AE Q37248599-4446CB9A-7536-4427-AF92-B356B9772001 Q37373524-544B305D-4CD5-495B-A4AC-B9980379DEEB Q37455225-EC14F04C-BF10-4FAC-8FE9-003D0AA5537C Q37593569-FC57A0E0-BDE3-48B0-BB02-68EF5688B3B7 Q37604704-BAC4E6B1-B4DB-40EB-B104-D4C2B2BE9641 Q38019642-866063E1-1ED2-4798-9433-CA572D2472E1 Q38063159-CDC619C4-DC0C-41AC-9B7B-72E4AC75C645

P2860

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

http://www.wikidata.org/entity/Q33756417

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@ast

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@en

type

label

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@ast

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@en

prefLabel

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@ast

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@en

P1433

Q33756417-D6B1B625-973E-45E7-B46D-AC067646B7DB

P1476

Q33756417-782D0153-1476-483D-BD42-735F42AC11EA

P2093

Q33756417-305DABB5-6E01-405D-8229-6A08DC16E8FF

Q33756417-56D5048E-7930-4F39-9C1C-36309E9E6C1B

Q33756417-D5651E0D-6612-4ACB-BACE-C356814E6798

Q33756417-E192CB88-C421-4970-8B05-EB7C17AFCF9E

P2860

Q33756417-055A6D8D-57EA-4E07-BC5D-36D5D4C4ADA2

Q33756417-0CDB0406-FCDD-4448-9E10-27FDBCDA9640

Q33756417-0F69739D-B997-4A6C-9C51-B51CAD10882C

Q33756417-13B65923-EAC5-4277-9591-0CCCBCE29A21

Q33756417-15214C0C-DC2B-48F7-9066-E1255A724C7A

Q33756417-15805F59-3BD2-403A-A84D-37A330DD60F7

Q33756417-1780F13B-DFAA-4B67-89BC-688773F4B589

Q33756417-3D6E65E2-6D4F-4BCE-A31A-10A78D59538A

Q33756417-44A48923-B9D9-4E00-8C91-230DD59B7029

Q33756417-4ABCE563-C372-4F91-8CFE-1FE358D2E766

P304

Q33756417-1001FBD8-4920-4CDB-9308-8230184E2232

P31

Q33756417-629239A2-5DF2-423E-A94E-D8C68B2C186B

P356

Q33756417-92405734-AF05-44AD-B804-187E01EC6588

P407

Q33756417-9B967ADD-B0B1-479F-BA87-9AC504C85742

P433

Q33756417-A5BF590E-A7A6-485A-9F83-E9A860281544

P478

Q33756417-A4B4D587-7825-452C-A179-E8B50B86D27E

P50

Q33756417-05C86180-FBB7-4986-8ACF-883E39B7AAF2

P577

Q33756417-6195620D-7F1E-42DD-A5F1-7EA0DFFF51DA

P5875

Q33756417-AA009116-6409-413A-8D7F-E11C6BEE0B59

P698

Q33756417-1E45174C-1D36-461E-BED4-FDA7ACB55394

P932

Q33756417-2D84D590-9595-444D-93F5-5AD4AB423410

P356

JIMMUNOL.0901851

P1433

Journal of Immunology

P1476

SP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.

@en

P2093

Holger K Eltzschig

http://www.w3.org/2001/XMLSchema#string

Iris C Gorzolla

http://www.w3.org/2001/XMLSchema#string

Melanie L Hart

http://www.w3.org/2001/XMLSchema#string

Simon C Robson

http://www.w3.org/2001/XMLSchema#string

P2860

The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.

Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography

The reno-vascular A2B adenosine receptor protects the kidney from ischemia

Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration

A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.

Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.

Adenosine: an old drug newly discovered.

P304

4017-4024

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0901851

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

Jens Schittenhelm

P577

2010-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41808609

http://www.w3.org/2001/XMLSchema#string

P698

20207994

http://www.w3.org/2001/XMLSchema#string

P932

2846294

http://www.w3.org/2001/XMLSchema#string